DR. DANIEL S BRADFORD M.D. NPI 1033180229

NPI Details

DR. Daniel S Bradford, M.D. is a hematology and oncology internal medicine in Rogers, AR. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. DR. Daniel S Bradford, M.D. NPI is 1033180229. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

808 S 52ND ST
ROGERS, AR
ZIP 72758-602
Phone: (479) 936-9900
Fax: (479) 587-1366

The NPI 1033180229 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
• Injection, gadoterate meglumine, 0.1 ml (HCPCS:A9575)
• Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, nivolumab, 1 mg (HCPCS:J9299)
• Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS:Q5101)
• Injection, oxaliplatin, 0.5 mg (HCPCS:J9263)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, paclitaxel, 1 mg (HCPCS:J9267)
• Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram (HCPCS:Q5110)
• Injection, daratumumab, 10 mg and hyaluronidase-fihj (HCPCS:J9144)
• Injection, fosaprepitant, 1 mg (HCPCS:J1453)
• Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg (HCPCS:J1561)
• Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units (HCPCS:Q5106)
• Injection, testosterone cypionate, 1 mg (HCPCS:J1071)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Injection, iron sucrose, 1 mg (HCPCS:J1756)
• Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
• Injection, rituximab-abbs, biosimilar, (truxima), 10 mg (HCPCS:Q5115)
• Injection, durvalumab, 10 mg (HCPCS:J9173)
• Injection, bortezomib (velcade), 0.1 mg (HCPCS:J9041)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg (HCPCS:Q5107)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Magnesium level (HCPCS:83735)
• Phosphate level (HCPCS:84100)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Uric acid level, blood (HCPCS:84550)
• Bilirubin level, direct (HCPCS:82248)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Thyroxine (thyroid chemical), total (HCPCS:84436)
• Ferritin (blood protein) level (HCPCS:82728)
• Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Injection, octreotide, depot form for intramuscular injection, 1 mg (HCPCS:J2353)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Injection, fulvestrant, 25 mg (HCPCS:J9395)
• Vitamin d-3 level (HCPCS:82306)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Folic acid level, serum (HCPCS:82746)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries (HCPCS:A9552)
• Ct scan of chest with contrast (HCPCS:71260)
• Nuclear medicine study from skull base to mid-thigh with ct scan (HCPCS:78815)
• Injection, fluorouracil, 500 mg (HCPCS:J9190)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Ct scan of abdomen and pelvis before and after contrast (HCPCS:74178)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg (HCPCS:J9201)
• Injection, etoposide, 10 mg (HCPCS:J9181)
• Cortisol (hormone) measurement, total (HCPCS:82533)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Ct scan of head or brain before and after contrast (HCPCS:70470)
• Ct scan of chest without contrast (HCPCS:71250)
• Cyclophosphamide, 100 mg (HCPCS:J9070)
• Mri scan of brain before and after contrast (HCPCS:70553)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Injection, pegfilgrastim-jmdb, biosimilar, (fulphila), 0.5 mg (HCPCS:Q5108)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Unclassified drugs (HCPCS:J3490)
• X-ray of chest, 2 views (HCPCS:71046)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Ct scan of abdomen and pelvis without contrast (HCPCS:74176)
• Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
• Injection, potassium chloride, per 2 meq (HCPCS:J3480)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
• Ct scan of soft tissue of neck with contrast (HCPCS:70491)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)
• Measurement of substance using immunoassay technique (HCPCS:83520)
• Manual urinalysis test with examination using microscope, non-automated (HCPCS:81000)
• Blood creatinine level (HCPCS:82565)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Piflufolastat f-18, diagnostic, 1 millicurie (HCPCS:A9595)
• Ct scan head or brain without contrast (HCPCS:70450)
• Blood test, clotting time (HCPCS:85610)
• Fee covid-19 vac 14 res (HCPCS:0134A)
• Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99490)
• Nuclear medicine study whole body with ct scan (HCPCS:78816)
• Limited ultrasound scan of abdomen (HCPCS:76705)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 125 (HCPCS:86304)
• Administration of chemotherapy into vein using push technique (HCPCS:96409)
• Glutamyltransferase (liver enzyme) level (HCPCS:82977)
• Administration of prolonged chemotherapy into vein (HCPCS:96416)
• Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99439)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Drawing of blood for a medical problem (HCPCS:99195)
• Beta-2 microglobulin (protein) level (HCPCS:82232)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Ct scan of soft tissue of neck without contrast (HCPCS:70490)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise (HCPCS:M0220)
• Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
• Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Injection, midazolam hydrochloride, per 1 mg (HCPCS:J2250)
• Injection of drug or substance into vein (HCPCS:96374)
• Adm sarscov2 30mcg/0.3ml bst (HCPCS:0004A)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Red blood cell sedimentation rate, to detect inflammation, non-automated (HCPCS:85651)
• Irrigation of implanted venous access drug delivery device (HCPCS:96523)
• Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) (HCPCS:G0506)
• Adm sarscov2 30mcg/0.3ml 3rd (HCPCS:0003A)
• Injection, meperidine hydrochloride, per 100 mg (HCPCS:J2175)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Ultrasound of heart with color-depicted blood flow, rate, direction and valve function (HCPCS:93306)
• Biopsy and aspiration of bone marrow sample for diagnosis (HCPCS:38222)
• Hospital discharge day management, 30 minutes or less (HCPCS:99238)
• Mri scan of lower spinal canal before and after contrast (HCPCS:72158)

The enumeration date for this NPI number is 1/27/2006 and was last updated on 3/30/2020.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.